ciprofloxacin has been researched along with Community Acquired Infection in 99 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged ≥18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days." | 9.16 | Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. ( Ekman, GS; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergård, A; Otto, G; Sandberg, T; Settergren, B; Skoog, G, 2012) |
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 9.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| "Antimicrobial resistance to ciprofloxacin is rising worldwide, especially in bacteria causing urinary tract infections (UTIs)." | 7.85 | Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. ( de Visser, H; Goessens, WH; Hofman, A; Kiefte-de Jong, JC; Mulder, M; Stricker, BH; Verbon, A, 2017) |
| "Moxifloxacin has potent bactericidal activity against Streptococcus pneumoniae; a major causative organism of lower respiratory tract infections." | 7.80 | Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios. ( Noreddin, AM; Salem, AH, 2014) |
| "In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged ≥18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days." | 5.16 | Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. ( Ekman, GS; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergård, A; Otto, G; Sandberg, T; Settergren, B; Skoog, G, 2012) |
| "We conducted a randomized controlled trial to determine whether empirical treatment of severe acute community-acquired gastroenteritis (four fluid stools per day for > 3 days) with ciprofloxacin reduces the duration of diarrhea and other symptoms and to determine what effect ciprofloxacin has on the duration of long-term fecal carriage of gastrointestinal pathogens." | 5.08 | Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. ( Dryden, MS; Gabb, RJ; Wright, SK, 1996) |
| " The vast majority of Enterobacteriaceae, including ESBL producers, remain susceptible to carbapenems, and these agents are considered preferred empiric therapy for serious Enterobacteriaceae infections." | 4.83 | Resistance in gram-negative bacteria: enterobacteriaceae. ( Paterson, DL, 2006) |
| "Considering the global concern of ciprofloxacin resistance, the aim of this study was to evaluate the characteristics of ciprofloxacin-resistant (CIP-R) Escherichia coli isolated from patients with community-acquired urinary tract infections (UTIs) in Brasília, Brazil." | 3.85 | Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. ( de Campos, TA; de Melo, ABF; de Oliveira Martins Júnior, P; de Paulo Martins, V; Gonçalves, LF; Moreira da Silva, RCR; Pitondo-Silva, A, 2017) |
| "Antimicrobial resistance to ciprofloxacin is rising worldwide, especially in bacteria causing urinary tract infections (UTIs)." | 3.85 | Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. ( de Visser, H; Goessens, WH; Hofman, A; Kiefte-de Jong, JC; Mulder, M; Stricker, BH; Verbon, A, 2017) |
| "Moxifloxacin has potent bactericidal activity against Streptococcus pneumoniae; a major causative organism of lower respiratory tract infections." | 3.80 | Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios. ( Noreddin, AM; Salem, AH, 2014) |
| "Discordant empirical therapy, mostly with ciprofloxacin, leads to worse early clinical response and longer hospital stay than concordant therapy in community-acquired bacteremic acute pyelonephritis, although it does not affect on overall mortality or clinical cure rate." | 3.77 | Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. ( Chung, DR; Kim, Y; Lee, SS, 2011) |
| "The in vitro activity of moxifloxacin was compared with that of ciprofloxacin, levofloxacin, ofloxacin and trovafloxacin against 710 strains (180 Streptococcus pneumoniae, 180 Haemophilus influenzae, 160 Moraxella catarrhalis and 190 Streptococcus pyogenes) isolated from patients with community-acquired respiratory tract infections." | 3.71 | Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens. ( Ambler, J; Cardeñosa, O; Lemme, L; Lopez, H; Scarano, S; Smayevsky, J; Stepanik, D; Sucari, A; Vilches, V, 2001) |
| "The efficacy and safety of Cifran OD, a new dosage form of ciprofloxacin with prolonged action were studied in the treatment of patients with bronchopulmonary infection (n=23)." | 2.71 | [Therapy of bronchopulmonary infection in smokers]. ( Orlov, VA; Shenderovich, VA; Smirnova, LB; Sokolova, VI; Surkova, IuV, 2004) |
| "coli bacteremia were due to QREC." | 2.69 | Emergence and dissemination of quinolone-resistant Escherichia coli in the community. ( Coll, I; Garau, J; Gómez-Vera, JR; Llovet, T; Rodríguez-Carballeira, M; Ruíz-Bremón, A; Vidal, D; Xercavins, M, 1999) |
| "For levofloxacin-treated CAP patients with P." | 2.43 | Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience. ( Davis, NB; Kahn, J; Tennenberg, AM; Wu, SC, 2006) |
| "Community-acquired pneumonia is associated with higher morbidity, hospitalization, and mortality in adults." | 1.72 | Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study. ( Assefa, M; Belachew, T; Tessema, B; Tigabu, A, 2022) |
| "The emergence of community acquired infections increases the public health concern on K." | 1.62 | Comparative genomics with a multidrug-resistant Klebsiella pneumoniae isolate reveals the panorama of unexplored diversity in Northeast Brazil. ( Azevedo, V; Barh, D; Brenig, B; Bücker, DH; Caetano, AC; Castro, TLP; Figueiredo, HCP; Gala-Garcia, A; Ghosh, P; Góes-Neto, A; Jaiswal, AK; Kato, RB; Lima-Verde, IB; Meyer, R; Padilha, FF; Profeta, R; Ramos, PIP; Santos, R; Seyffert, N; Soares, SC; Tavares de Oliveira, L; Tiwari, S; Viana, MVC, 2021) |
| "We present an interesting case of Legionnaires' disease masquerading as acute pyelonephritis, with complete absence of respiratory symptoms on admission." | 1.42 | A rare presentation of Legionnaires' disease. ( Banerjee, A; Delicata, M, 2015) |
| "The aims of the study were to develop a population pharmacokinetic model of ciprofloxacin (CPX) in the elderly patients and to examine the impact of patient-dependent variables on pharmacokinetic parameter values of this drug." | 1.40 | Population pharmacokinetic analysis of ciprofloxacin in the elderly patients with lower respiratory tract infections. ( Cios, A; Grodzicki, T; Szymura-Oleksiak, J; Wyska, E, 2014) |
| "Ciprofloxacin was given to 97% patients along with fluid administration, and 78% were found to be resistant to quinolones." | 1.38 | Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis. ( Anwar, MA; Awan, S; Hilal, H; Khan, MS; Patel, MJ; Razi, S; Riaz, MM; Tariq, M, 2012) |
| "Since 2002, an epidemic of Clostridium difficile infections has occurred in southern Quebec, Canada." | 1.35 | Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. ( Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M, 2008) |
| "Moxifloxacin is a respiratory fluoroquinolone with a community acquired pneumonia indication." | 1.35 | Fluoroquinolone resistance during 2000-2005: an observational study. ( Lindsell, C; Ryan, RJ; Sheehan, P, 2008) |
| "Clarithromycin resistance was 12% in M." | 1.33 | Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia. ( Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E, 2006) |
| "Trovafloxacin was 2-4 times more active than ciprofloxacin against both groups of strains." | 1.31 | Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin. ( Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM, 2001) |
| "catarrhalis produced beta-lactamase." | 1.30 | Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season. ( Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (14.14) | 18.2507 |
| 2000's | 44 (44.44) | 29.6817 |
| 2010's | 35 (35.35) | 24.3611 |
| 2020's | 6 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Mendonça, N | 1 |
| Leitão, J | 1 |
| Manageiro, V | 1 |
| Ferreira, E | 1 |
| Caniça, M | 1 |
| Daikos, GL | 1 |
| Kosmidis, C | 1 |
| Tassios, PT | 1 |
| Petrikkos, G | 2 |
| Vasilakopoulou, A | 1 |
| Psychogiou, M | 1 |
| Stefanou, I | 1 |
| Avlami, A | 2 |
| Katsilambros, N | 1 |
| Lartigue, MF | 1 |
| Zinsius, C | 1 |
| Wenger, A | 1 |
| Bille, J | 1 |
| Poirel, L | 1 |
| Nordmann, P | 1 |
| Labbé, AC | 1 |
| Poirier, L | 1 |
| Maccannell, D | 1 |
| Louie, T | 1 |
| Savoie, M | 1 |
| Béliveau, C | 1 |
| Laverdière, M | 1 |
| Pépin, J | 1 |
| Peirano, G | 1 |
| Richardson, D | 1 |
| Nigrin, J | 1 |
| McGeer, A | 1 |
| Loo, V | 1 |
| Toye, B | 1 |
| Alfa, M | 1 |
| Pienaar, C | 1 |
| Kibsey, P | 1 |
| Pitout, JD | 1 |
| Assefa, M | 1 |
| Tigabu, A | 1 |
| Belachew, T | 1 |
| Tessema, B | 1 |
| Mustapha, SS | 1 |
| Ibrahim, M | 1 |
| Aliyu, S | 1 |
| Abdulkadir, I | 1 |
| Nielsen, RT | 1 |
| Andersen, CØ | 1 |
| Schønheyder, HC | 1 |
| Petersen, JH | 1 |
| Knudsen, JD | 1 |
| Jarløv, JO | 1 |
| Norredam, M | 1 |
| Araújo, MRB | 1 |
| Sant'Anna, LO | 1 |
| Santos, NNCD | 1 |
| Seabra, LF | 1 |
| Santos, LSD | 1 |
| Stapleton, AE | 1 |
| Wagenlehner, FME | 1 |
| Mulgirigama, A | 1 |
| Twynholm, M | 1 |
| Profeta, R | 1 |
| Seyffert, N | 1 |
| Tiwari, S | 1 |
| Viana, MVC | 1 |
| Jaiswal, AK | 1 |
| Caetano, AC | 1 |
| Bücker, DH | 1 |
| Tavares de Oliveira, L | 1 |
| Santos, R | 1 |
| Gala-Garcia, A | 1 |
| Kato, RB | 1 |
| Padilha, FF | 1 |
| Lima-Verde, IB | 1 |
| Ghosh, P | 1 |
| Barh, D | 1 |
| Góes-Neto, A | 1 |
| Figueiredo, HCP | 1 |
| Soares, SC | 1 |
| Meyer, R | 1 |
| Brenig, B | 1 |
| Ramos, PIP | 1 |
| Azevedo, V | 1 |
| Castro, TLP | 1 |
| Moreira da Silva, RCR | 1 |
| de Oliveira Martins Júnior, P | 1 |
| Gonçalves, LF | 1 |
| de Paulo Martins, V | 1 |
| de Melo, ABF | 1 |
| Pitondo-Silva, A | 1 |
| de Campos, TA | 1 |
| Gökçe, İ | 1 |
| Çiçek, N | 1 |
| Güven, S | 1 |
| Altuntaş, Ü | 1 |
| Bıyıklı, N | 1 |
| Yıldız, N | 1 |
| Alpay, H | 1 |
| Bosch-Nicolau, P | 1 |
| Falcó, V | 1 |
| Viñado, B | 1 |
| Andreu, A | 1 |
| Len, O | 1 |
| Almirante, B | 1 |
| Pigrau, C | 1 |
| Batard, E | 1 |
| Vibet, MA | 1 |
| Thibaut, S | 1 |
| Corvec, S | 1 |
| Pivette, J | 1 |
| Lepelletier, D | 1 |
| Caillon, J | 1 |
| Montassier, E | 1 |
| Yamaji, R | 1 |
| Rubin, J | 1 |
| Thys, E | 1 |
| Friedman, CR | 1 |
| Riley, LW | 1 |
| Rahdar, HA | 1 |
| Kazemian, H | 1 |
| Bimanand, L | 1 |
| Shahraki-Zahedani, S | 1 |
| Feyisa, SG | 1 |
| Taki, E | 1 |
| Havaei, SA | 1 |
| Karami-Zarandi, M | 1 |
| Dewart, CM | 1 |
| Gao, Y | 1 |
| Rahman, P | 1 |
| Mbodj, A | 1 |
| Hade, EM | 1 |
| Stevenson, K | 1 |
| Hebert, CL | 1 |
| Hayakawa, K | 1 |
| Gattu, S | 1 |
| Marchaim, D | 1 |
| Bhargava, A | 1 |
| Palla, M | 1 |
| Alshabani, K | 1 |
| Gudur, UM | 1 |
| Pulluru, H | 1 |
| Bathina, P | 1 |
| Sundaragiri, PR | 1 |
| Sarkar, M | 1 |
| Kakarlapudi, H | 1 |
| Ramasamy, B | 1 |
| Nanjireddy, P | 1 |
| Mohin, S | 1 |
| Dasagi, M | 1 |
| Datla, S | 1 |
| Kuchipudi, V | 1 |
| Reddy, S | 1 |
| Shahani, S | 1 |
| Upputuri, V | 1 |
| Marrey, S | 1 |
| Gannamani, V | 1 |
| Madhanagopal, N | 1 |
| Annangi, S | 1 |
| Sudha, B | 1 |
| Muppavarapu, KS | 1 |
| Moshos, JA | 1 |
| Lephart, PR | 1 |
| Pogue, JM | 1 |
| Bush, K | 1 |
| Kaye, KS | 1 |
| Salem, AH | 1 |
| Noreddin, AM | 1 |
| Cios, A | 1 |
| Wyska, E | 1 |
| Szymura-Oleksiak, J | 1 |
| Grodzicki, T | 1 |
| Seo, MR | 1 |
| Kim, SJ | 1 |
| Kim, Y | 2 |
| Kim, J | 1 |
| Choi, TY | 1 |
| Kang, JO | 1 |
| Wie, SH | 1 |
| Ki, M | 1 |
| Cho, YK | 1 |
| Lim, SK | 2 |
| Lee, JS | 1 |
| Kwon, KT | 2 |
| Lee, H | 1 |
| Cheong, HJ | 2 |
| Park, DW | 1 |
| Ryu, SY | 1 |
| Chung, MH | 1 |
| Pai, H | 1 |
| Wang, JY | 1 |
| Lee, CH | 2 |
| Yu, MC | 1 |
| Lee, MC | 1 |
| Lee, LN | 1 |
| Wang, JT | 1 |
| Nakasone, ES | 1 |
| Kaneshiro, R | 1 |
| Min, K | 1 |
| Tokeshi, J | 2 |
| Delicata, M | 1 |
| Banerjee, A | 1 |
| Rosé, L | 1 |
| Coulter, MM | 1 |
| Chan, S | 1 |
| Hossain, J | 1 |
| Di Pentima, MC | 1 |
| Zhang, H | 1 |
| Yang, Q | 1 |
| Liao, K | 1 |
| Ni, Y | 1 |
| Yu, Y | 1 |
| Hu, B | 1 |
| Sun, Z | 1 |
| Huang, W | 1 |
| Wang, Y | 1 |
| Wu, A | 1 |
| Feng, X | 1 |
| Luo, Y | 1 |
| Hu, Z | 1 |
| Chu, Y | 1 |
| Chen, S | 1 |
| Cao, B | 1 |
| Su, J | 1 |
| Gui, B | 1 |
| Duan, Q | 1 |
| Zhang, S | 1 |
| Shao, H | 1 |
| Kong, H | 1 |
| Badal, RE | 1 |
| Xu, Y | 1 |
| Fasugba, O | 1 |
| Gardner, A | 1 |
| Mitchell, BG | 1 |
| Mnatzaganian, G | 1 |
| Morganti, L | 1 |
| Córdova, E | 1 |
| Cassini, E | 1 |
| Gómez, N | 1 |
| López Moral, L | 1 |
| Badía, M | 1 |
| Rodríguez, C | 1 |
| Reis, AC | 1 |
| Santos, SR | 1 |
| Souza, SC | 1 |
| Saldanha, MG | 1 |
| Pitanga, TN | 1 |
| Oliveira, RR | 1 |
| Mulder, M | 1 |
| Kiefte-de Jong, JC | 1 |
| Goessens, WH | 1 |
| de Visser, H | 1 |
| Hofman, A | 1 |
| Stricker, BH | 1 |
| Verbon, A | 1 |
| Otter, JA | 2 |
| French, GL | 2 |
| Cagnacci, S | 1 |
| Gualco, L | 1 |
| Debbia, E | 1 |
| Schito, GC | 1 |
| Marchese, A | 1 |
| Turtle, L | 1 |
| Wey, E | 1 |
| James, E | 1 |
| Tattevin, P | 1 |
| Basuino, L | 1 |
| Chambers, HF | 1 |
| Ellington, MJ | 1 |
| Perry, C | 1 |
| Ganner, M | 1 |
| Warner, M | 1 |
| McCormick Smith, I | 1 |
| Hill, RL | 1 |
| Shallcross, L | 1 |
| Sabersheikh, S | 1 |
| Holmes, A | 1 |
| Cookson, BD | 1 |
| Kearns, AM | 1 |
| Gottesman, BS | 1 |
| Carmeli, Y | 1 |
| Shitrit, P | 1 |
| Chowers, M | 1 |
| Arredondo-García, JL | 1 |
| Amábile-Cuevas, CF | 1 |
| Kothari, A | 1 |
| Sagar, V | 1 |
| Lee, MY | 1 |
| Choi, HJ | 1 |
| Choi, JY | 1 |
| Song, M | 1 |
| Song, Y | 1 |
| Kim, SW | 1 |
| Chang, HH | 1 |
| Jung, SI | 1 |
| Kim, YS | 1 |
| Ki, HK | 1 |
| Son, JS | 1 |
| Heo, ST | 1 |
| Yeom, JS | 1 |
| Shin, SY | 1 |
| Chung, DR | 2 |
| Peck, KR | 1 |
| Song, JH | 1 |
| Ko, KS | 1 |
| Miller, R | 1 |
| Walker, AS | 1 |
| Knox, K | 1 |
| Wyllie, D | 1 |
| Paul, J | 1 |
| Haworth, E | 1 |
| Mant, D | 1 |
| Peto, T | 1 |
| Crook, DW | 1 |
| Klein, M | 1 |
| Pfister, HW | 1 |
| Lee, SS | 1 |
| Crivellaro, S | 1 |
| Leone, I | 1 |
| Bianco, O | 1 |
| Savoia, D | 1 |
| Mera, RM | 1 |
| Suaya, JA | 1 |
| Amrine-Madsen, H | 1 |
| Hogea, CS | 1 |
| Miller, LA | 1 |
| Lu, EP | 1 |
| Sahm, DF | 1 |
| O'Hara, P | 1 |
| Acosta, CJ | 1 |
| Bhattacharya, SS | 1 |
| Das, U | 1 |
| Choudhury, BK | 1 |
| Cardinale, F | 1 |
| Chironna, M | 1 |
| Dumke, R | 1 |
| Binetti, A | 1 |
| Daleno, C | 1 |
| Sallustio, A | 1 |
| Valzano, A | 1 |
| Esposito, S | 1 |
| Hoshide, RR | 1 |
| Chung, H | 1 |
| Park, IW | 1 |
| Lee, WG | 1 |
| Kim, HK | 1 |
| Choi, YH | 1 |
| Riaz, MM | 1 |
| Patel, MJ | 1 |
| Khan, MS | 1 |
| Anwar, MA | 1 |
| Tariq, M | 1 |
| Hilal, H | 1 |
| Awan, S | 1 |
| Razi, S | 1 |
| Cullen, IM | 1 |
| Manecksha, RP | 1 |
| McCullagh, E | 1 |
| Ahmad, S | 1 |
| O'Kelly, F | 1 |
| Flynn, R | 1 |
| McDermott, TE | 1 |
| Murphy, P | 1 |
| Grainger, R | 1 |
| Fennell, JP | 1 |
| Thornhill, JA | 1 |
| Sandberg, T | 1 |
| Skoog, G | 1 |
| Hermansson, AB | 1 |
| Kahlmeter, G | 1 |
| Kuylenstierna, N | 1 |
| Lannergård, A | 1 |
| Otto, G | 1 |
| Settergren, B | 1 |
| Ekman, GS | 1 |
| Ortega, M | 1 |
| Marco, F | 1 |
| Soriano, A | 1 |
| Almela, M | 1 |
| Martínez, JA | 1 |
| Pitart, C | 1 |
| Mensa, J | 1 |
| Astal, Z | 1 |
| El-Manama, A | 1 |
| Sharif, FA | 1 |
| Illinger, J | 1 |
| Mohammedi, I | 1 |
| Martin, O | 1 |
| Argaud, L | 1 |
| St Denis, M | 1 |
| Robert, D | 1 |
| Fujita, M | 1 |
| Ishibashi, T | 1 |
| Hara, N | 1 |
| Yoshida, M | 1 |
| Yamada, H | 1 |
| Chaniotaki, S | 1 |
| Giakouppi, P | 1 |
| Tzouvelekis, LS | 1 |
| Panagiotakos, D | 1 |
| Kozanitou, M | 1 |
| Vatopoulos, AC | 1 |
| Talon, D | 1 |
| Lallemand-De-Conto, S | 1 |
| Thouverez, M | 1 |
| Bertrand, X | 1 |
| Sokolova, VI | 1 |
| Orlov, VA | 1 |
| Surkova, IuV | 1 |
| Shenderovich, VA | 1 |
| Smirnova, LB | 1 |
| Baker, SD | 1 |
| Horger, DC | 1 |
| Keane, TE | 1 |
| Ko, WC | 1 |
| Yan, JJ | 1 |
| Yu, WL | 1 |
| Lee, HC | 1 |
| Lee, NY | 1 |
| Wang, LR | 1 |
| Chuang, YC | 1 |
| Alonso, R | 1 |
| Mateo, E | 1 |
| Galimand, M | 1 |
| Garaizar, J | 1 |
| Courvalin, P | 1 |
| Cisterna, R | 1 |
| Arslan, H | 1 |
| Azap, OK | 1 |
| Ergönül, O | 1 |
| Timurkaynak, F | 1 |
| Allan, RC | 1 |
| Moghal, M | 1 |
| Wijesuriya, V | 1 |
| Melzer, M | 1 |
| Tennenberg, AM | 1 |
| Davis, NB | 1 |
| Wu, SC | 1 |
| Kahn, J | 1 |
| Paterson, DL | 1 |
| Song, JY | 1 |
| Jung, SJ | 1 |
| Park, CW | 1 |
| Sohn, JW | 1 |
| Kim, WJ | 1 |
| Kim, MJ | 1 |
| Kang, CI | 1 |
| Kim, SH | 1 |
| Bang, JW | 1 |
| Kim, HB | 1 |
| Kim, NJ | 1 |
| Kim, EC | 1 |
| Oh, MD | 1 |
| Choe, KW | 1 |
| Brezzo, C | 1 |
| Cecchini, D | 1 |
| Biscione, F | 1 |
| Orduna, T | 1 |
| Costa, N | 1 |
| Quinteros, M | 1 |
| Altraja, A | 1 |
| Naaber, P | 1 |
| Tamm, E | 1 |
| Meriste, S | 1 |
| Kullamaa, A | 1 |
| Leesik, H | 1 |
| Guss, J | 1 |
| Kazahaya, K | 1 |
| Vandijck, DM | 1 |
| Decruyenaere, JM | 1 |
| Depuydt, PO | 1 |
| Blot, SI | 1 |
| Lin, WC | 1 |
| Chia, JH | 1 |
| Su, LH | 1 |
| Chien, CC | 1 |
| Mao, AH | 1 |
| Liu, JW | 1 |
| Lin, AE | 1 |
| Davies, JE | 1 |
| Rock, W | 1 |
| Colodner, R | 1 |
| Chazan, B | 1 |
| Elias, M | 1 |
| Raz, R | 1 |
| Okimoto, N | 1 |
| Nanba, F | 1 |
| Kibayashi, T | 1 |
| Kishimoto, M | 1 |
| Yamato, K | 1 |
| Kurihara, T | 1 |
| Honda, Y | 1 |
| Osaki, K | 1 |
| Asaoka, N | 1 |
| Ryan, RJ | 1 |
| Lindsell, C | 1 |
| Sheehan, P | 1 |
| Körner, RJ | 1 |
| Reeves, DS | 1 |
| MacGowan, AP | 1 |
| Dryden, MS | 1 |
| Gabb, RJ | 1 |
| Wright, SK | 1 |
| Goldstein, FW | 1 |
| Acar, JF | 1 |
| Felmingham, D | 1 |
| Robbins, MJ | 1 |
| Tesfaslasie, Y | 1 |
| Harding, I | 1 |
| Shrimpton, S | 1 |
| Grüneberg, RN | 1 |
| Weber, P | 1 |
| Mombelli, G | 1 |
| Pezzoli, R | 1 |
| Pinoja-Lutz, G | 1 |
| Monotti, R | 1 |
| Marone, C | 1 |
| Franciolli, M | 1 |
| Hershow, RC | 1 |
| Khayr, WF | 1 |
| Schreckenberger, PC | 1 |
| Vikram, HR | 1 |
| Shore, ET | 1 |
| Venkatesh, PR | 1 |
| Lipsky, BA | 1 |
| Miller, B | 1 |
| Schwartz, R | 1 |
| Henry, DC | 2 |
| Nolan, T | 1 |
| McCabe, A | 1 |
| Magner, DJ | 2 |
| Talbot, GH | 2 |
| Nenad, RC | 1 |
| Iravani, A | 1 |
| Tice, AD | 1 |
| Mansfield, DL | 1 |
| Dorr, MB | 1 |
| Garau, J | 1 |
| Xercavins, M | 1 |
| Rodríguez-Carballeira, M | 1 |
| Gómez-Vera, JR | 1 |
| Coll, I | 1 |
| Vidal, D | 1 |
| Llovet, T | 1 |
| Ruíz-Bremón, A | 1 |
| Marre, R | 1 |
| Trautmann, M | 1 |
| Orrett, FA | 1 |
| Pillai, A | 1 |
| Mitchell, JL | 1 |
| Hill, SL | 1 |
| Stockley, RA | 1 |
| Lqbal, J | 1 |
| Rahman, M | 1 |
| Kabir, MS | 1 |
| Howard, AJ | 1 |
| Magee, JT | 1 |
| Fitzgerald, KA | 1 |
| Dunstan, FD | 1 |
| Milkovich, G | 1 |
| Stewart, JM | 1 |
| Quirk, JR | 1 |
| Lopez, H | 1 |
| Vilches, V | 1 |
| Scarano, S | 1 |
| Stepanik, D | 1 |
| Smayevsky, J | 1 |
| Lemme, L | 1 |
| Cardeñosa, O | 1 |
| Ambler, J | 1 |
| Sucari, A | 1 |
| Carabias, ML | 1 |
| Cervera, LA | 1 |
| García-Navas, BL | 1 |
| entelles, ML | 1 |
| Sánchez-Silos, RM | 1 |
| Pérez-Giraldo, C | 1 |
| Blanco, MT | 1 |
| Morán, FJ | 1 |
| Hurtado, C | 1 |
| Gómez-García, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antimicrobial Resistance Profiles in Healthcare Facilities From Meta State, Colombia: A Retrospective Observational Study From 2018-2022[NCT06044272] | 10,000 participants (Anticipated) | Observational | 2023-09-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for ciprofloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review.
Topics: Anti-Bacterial Agents; Asia; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacteria | 2020 |
Community Acquired Pseudomonas Aeruginosa Pneumonia in a Young Athlete Man: A Case Report and Literature Review.
Topics: Adult; Athletes; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Fatal Outcome; Femal | 2018 |
Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Esc | 2015 |
[Could it be bacterial meningitis?].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Communi | 2006 |
Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Re | 2006 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community- | 2006 |
Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Chryseobacterium; Ciprofloxacin; Community-Acquired Infections; Female; | 2008 |
8 trials available for ciprofloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Community-Acquired In | 2012 |
[Therapy of bronchopulmonary infection in smokers].
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Ciprofloxacin; Colony Count, Microbial; Com | 2004 |
[Clinical effects of intravenous ciprofloxacin on community-acquired pneumonia with positive Immunocard Mycoplasma test results].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Biomarkers; Ciprofloxacin; Community-Acquired | 2008 |
Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin.
Topics: Adult; Age Factors; Aged; Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Community- | 1996 |
Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, | 1999 |
Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Double-Blind Method; Fem | 1999 |
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin | 1999 |
Emergence and dissemination of quinolone-resistant Escherichia coli in the community.
Topics: Aged; Animals; Animals, Domestic; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Community-Acquir | 1999 |
84 other studies available for ciprofloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug R | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multipl | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobac | 2007 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acqu | 2008 |
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia col | 2010 |
Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Community-Acquired I | 2022 |
Enterobacter agglomerans, an uncommon cause of community-acquired bacterial infection in neonates.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Community-Acquired Infections; Enterobac | 2022 |
Differences in the distribution of pathogens and antimicrobial resistance in bloodstream infections in migrants compared with non-migrants in Denmark.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Community-Acquired Infections; Denmark; Drug Resis | 2023 |
Monitoring fluoroquinolone resistance among ESBL-positive and ESBL-negative Escherichia coli strains isolated from urinary tract infections: An alert for empirical treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Community-Acquired Infections; Escherichia co | 2023 |
Comparative genomics with a multidrug-resistant Klebsiella pneumoniae isolate reveals the panorama of unexplored diversity in Northeast Brazil.
Topics: Adult; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; G | 2021 |
Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
Topics: Anti-Bacterial Agents; Brazil; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacter | 2017 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazo | 2017 |
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2017 |
Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multipl | 2018 |
Persistent Pandemic Lineages of Uropathogenic Escherichia coli in a College Community from 1999 to 2017.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; California; Ciprofloxacin; Community-Acquired In | 2018 |
Penicillin allergy and association with ciprofloxacin coverage in community-onset urinary tract infection.
Topics: Antimicrobial Stewardship; Ciprofloxacin; Community-Acquired Infections; Drug Hypersensitivity; Drug | 2018 |
Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
Topics: Aged; Aged, 80 and over; Ambulatory Care; beta-Lactamases; Case-Control Studies; Ciprofloxacin; Comm | 2013 |
Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios.
Topics: Area Under Curve; Bronchopneumonia; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, B | 2014 |
Population pharmacokinetic analysis of ciprofloxacin in the elderly patients with lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; | 2014 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired In | 2014 |
Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; | 2015 |
Emergence of Raoultella ornithinolytica on O'ahu: a case of community-acquired R. ornithinolytica urinary tract infection.
Topics: Ciprofloxacin; Community-Acquired Infections; Female; Humans; Klebsiella Infections; Urinary Tract I | 2015 |
A rare presentation of Legionnaires' disease.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Ciprofloxacin; Community-Acquired Infections; Diagnosis, | 2015 |
Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprof | 2016 |
[Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina].
Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Commu | 2016 |
CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTION.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciproflo | 2016 |
Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Ciprofloxacin; Community-Acqui | 2017 |
The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006.
Topics: Adult; Bacterial Typing Techniques; Ciprofloxacin; Community-Acquired Infections; DNA, Bacterial; Ho | 2008 |
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Ciprofloxacin; Cluster A | 2008 |
Severe pneumonia caused by ciprofloxacin resistant panton-valentine leukocidin producing community acquired meticillin resistant Staphylococcus aureus.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Ciprofloxacin; Community-Acquired Infect | 2009 |
Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Comm | 2009 |
Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Bacterial Typin | 2009 |
Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Community-Ac | 2009 |
High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Mu | 2008 |
Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Infective Agents, Urinary; Ciprofloxacin; Community-Acquir | 2008 |
Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Cluster Analysis; Community-Acqui | 2010 |
'Feral' and 'wild'-type methicillin-resistant Staphylococcus aureus in the United Kingdom.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Bacterial Typin | 2010 |
Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Antigens, Bacterial; | 2011 |
Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cohort Studies; Community-Acquired Infection | 2011 |
Surveillance of methicillin-resistant Staphylococcus aureus isolated in Torino (northwest Italy).
Topics: Anti-Bacterial Agents; Bacterial Toxins; Bacterial Typing Techniques; Ciprofloxacin; Community-Acqui | 2011 |
Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Data | 2011 |
Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance | 2011 |
Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.
Topics: Anti-Bacterial Agents; C-Reactive Protein; Child; Ciprofloxacin; Community-Acquired Infections; Drug | 2011 |
Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti- | 2011 |
Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Dru | 2012 |
Clinical characteristics and predictors of positive stool culture in adult patients with acute gastroenteritis.
Topics: Acute Disease; Adult; Age Distribution; Campylobacter; Ciprofloxacin; Community-Acquired Infections; | 2012 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; | 2013 |
Epidemiology and prognostic determinants of bacteremic acute pyelonephritis in women.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Female; Humans; Inappropriate P | 2013 |
Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Community-Acquired Infections; D | 2002 |
[Community-acquired Pseudomonas aeruginosa bacteremic pneumonia in a "healthy" subject].
Topics: Adult; Anti-Infective Agents; Bacteremia; Bronchoalveolar Lavage; Ciprofloxacin; Community-Acquired | 2003 |
[The effect of intravenous ciprofloxacin for community acquired pneumonia in adults].
Topics: Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Drug Administration Schedule; F | 2003 |
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
Topics: Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Topoisomerase I | 2004 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; | 2004 |
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; | 2004 |
A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftriaxone; Ciproflox | 2005 |
Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.
Topics: Bacterial Proteins; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; | 2005 |
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Communi | 2005 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; | 2006 |
Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Community-Acquired Inf | 2006 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Commu | 2006 |
[Community-acquired methicillin-resistant Staphylococcus aureus disseminated disease].
Topics: Abscess; Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Humans; Male; M | 2006 |
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; C | 2006 |
Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Com | 2007 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cro | 2007 |
Occurrence of highly fluoroquinolone-resistant and methicillin-resistant Staphylococcus aureus in domestic animals.
Topics: Animals; Animals, Domestic; Anti-Infective Agents; Cat Diseases; Cats; Chickens; Ciprofloxacin; Comm | 2007 |
Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents, Urinary; Ciprofloxacin; Commun | 2007 |
Fluoroquinolone resistance during 2000-2005: an observational study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Community-Acquired Infec | 2008 |
Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Community-Acquired Infections; Female; Humans; Mal | 1994 |
Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Ciprofloxacin; Community-Acquired Infections; Drug Re | 1996 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Age | 1998 |
[Bacteriology in community-acquired respiratory pathology].
Topics: Acute Disease; Ambulatory Care; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprof | 1998 |
Ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: associated factors and resistance to other antibiotics.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Case-Control Studies; Chicago; Ciprofloxacin; Commun | 1998 |
Community acquired Pseudomonas aeruginosa pneumonia.
Topics: Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Humans; Male; Middle Aged; Pneu | 1999 |
[Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Communi | 1999 |
Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Topics: Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Erythromy | 1999 |
A case of Haemophilus parainfluenzae pneumonia.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Blood Sedimentation; C-Reactive Protein; Ciprof | 2000 |
Ciprofloxacin resistanceamong community-derived methicillin-resistant Staphylococcus aureus (MRSA) strains.
Topics: Anti-Infective Agents; Bangladesh; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Mu | 1999 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicilli | 2001 |
Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience.
Topics: Administration, Oral; Aged; Anti-Infective Agents; APACHE; Ciprofloxacin; Community-Acquired Infecti | 2001 |
Community-acquired pneumonia caused by Enterobacter asburiae.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Enterobacteriaceae Infec | 2001 |
Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Community-Acquired Infections; Fluoro | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Dr | 2001 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross In | 2001 |